How Can Specialty Pharmacies Prepare for New Orphan Drugs?

Joy Gilbert, vice president of operations at US Bioservices, gives advice about how specialty pharmacies need to prepare for new drug approvals.

Joy Gilbert, vice president of operations at US Bioservices, a part of AmerisourceBergen, gives advice about how specialty pharmacies need to prepare for new drug approvals.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

How Can Specialty Pharmacies Prepare for New Orphan Drugs?

Newsletter